Medicare Enrolled
Dr. Henna Malik, M.D.
Internal Medicine · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Malik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malik
Dr. Henna Malik is an internal medicine specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Malik performed 46,507 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Malik received a total of $276,801 from 78 pharmaceutical and/or device companies across 698 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in TX
$276,801 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗46,507
Medicare services
Top 1% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
21,420 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
7,600 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
6,020 | $2 | $20 |
| Pembrolizumab injection (Keytruda) | 5,200 | $43 | $136 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $18 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
784 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
617 | $8 | $36 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
325 | $8 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
300 | $98 | $369 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $66 | $250 |
| Injection, granisetron hydrochloride, 100 mcg | 210 | $0 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
153 | $104 | $707 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
137 | $23 | $157 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
113 | $10 | $64 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
107 | $12 | $108 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
105 | $11 | $96 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
92 | $48 | $313 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
81 | $23 | $161 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
55 | $35 | $143 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
49 | $1 | $7 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $36 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $141 | $496 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
43 | $52 | $344 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $116 | $565 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
26 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
26 | $6 | $34 |
| New patient office visit, complex (60-74 min) | 26 | $178 | $709 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
19 | $74 | $264 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
15 | $79 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
47.0% high complexity
48.9% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$276,801
Total received (2018-2024)
Avg $39,543/year across 7 years
Top 1% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
698
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$68,212
2023
$91,307
2022
$52,997
2021
$25,828
2020
$11,733
2019
$18,200
2018
$8,524
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$40,552
Regeneron Healthcare Solutions, Inc.
$8,679
Astellas Pharma US Inc
$8,152
E.R. Squibb & Sons, L.L.C.
$4,880
Regeneron Pharmaceuticals, Inc.
$2,970
Tempus AI, Inc
$326
Novartis Pharmaceuticals Corporation
$270
PFIZER INC.
$241
Eisai Inc.
$236
SpringWorks Therapeutics, Inc.
$236
Janssen Biotech, Inc.
$164
Celgene Corporation
$154
ADC Therapeutics America, Inc.
$140
Myriad Genetic Laboratories, Inc.
$112
SOBI, INC
$105
Daiichi Sankyo Inc.
$100
ABBVIE INC.
$92
GlaxoSmithKline, LLC.
$75
JAZZ PHARMACEUTICALS INC.
$68
PharmaEssentia USA Corporation
$59
Adaptive Biotechnologies Corporation
$59
PUMA BIOTECHNOLOGY, INC.
$50
Deciphera Pharmaceuticals Inc.
$48
EMD Serono, Inc.
$48
BeiGene USA, Inc.
$45
Fennec Pharmaceuticals, Inc.
$42
Ipsen Biopharmaceuticals, Inc
$34
Kite Pharma, Inc.
$29
Gilead Sciences, Inc.
$28
Immunocore Limited
$25
Sirtex Medical Inc
$25
TerSera Therapeutics LLC
$24
Mirati Therapeutics, Inc.
$22
Exelixis Inc.
$21
Menarini Silicon Biosystems, Inc.
$21
ARRAY BIOPHARMA INC
$18
Legend Biotech USA Inc.
$17
Genentech USA, Inc.
$16
Amgen Inc.
$16
GENZYME CORPORATION
$13
Top 3 companies account for 84.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$70,859
Regeneron Healthcare Solutions, Inc.
$60,627
E.R. Squibb & Sons, L.L.C.
$30,739
PharmaEssentia USA Corporation
$22,222
GENZYME CORPORATION
$17,545
Astellas Pharma US Inc
$15,981
Seagen Inc.
$12,551
Gilead Sciences, Inc.
$5,390
ARRAY BIOPHARMA INC
$5,144
Exelixis Inc.
$4,806
Genentech USA, Inc.
$4,140
Celgene Corporation
$3,409
Sirtex Medical Inc
$3,302
Regeneron Pharmaceuticals, Inc.
$3,112
Eisai Inc.
$3,103
Mirati Therapeutics, Inc.
$1,935
Seattle Genetics, Inc.
$1,716
Janssen Biotech, Inc.
$1,626
Pharmacosmos Therapeutics Inc.
$1,500
Bayer Healthcare Pharmaceuticals Inc.
$678
Novartis Pharmaceuticals Corporation
$619
Lilly USA, LLC
$574
PFIZER INC.
$507
Incyte Corporation
$403
Myriad Genetic Laboratories, Inc.
$370
Tempus AI, Inc
$326
Foundation Medicine, Inc.
$310
Amgen Inc.
$297
SpringWorks Therapeutics, Inc.
$236
GlaxoSmithKline, LLC.
$211
EISAI INC.
$180
Athenex Pharmaceutical Division, LLC
$175
ADC Therapeutics America, Inc.
$140
SOBI, INC
$137
MorphoSys, US Inc.
$115
ABBVIE INC.
$106
Daiichi Sankyo Inc.
$100
Dendreon Pharmaceuticals LLC
$99
Takeda Pharmaceuticals U.S.A., Inc.
$94
Intuitive Surgical, Inc.
$92
BeiGene USA, Inc.
$83
PUMA BIOTECHNOLOGY, INC.
$76
Tactile Systems Technology Inc
$73
Adaptive Biotechnologies Corporation
$73
Deciphera Pharmaceuticals Inc.
$73
EMD Serono, Inc.
$71
JAZZ PHARMACEUTICALS INC.
$68
Fennec Pharmaceuticals, Inc.
$60
Merck Sharp & Dohme LLC
$57
TerSera Therapeutics LLC
$48
Dova Pharmaceuticals
$47
Ipsen Biopharmaceuticals, Inc
$34
CTI BioPharma Corp.
$33
Kite Pharma, Inc.
$29
Myovant Sciences Inc.
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Blueprint Medicines Corporation
$28
Pharmacyclics LLC, An AbbVie Company
$26
Immunocore Limited
$25
TAIHO ONCOLOGY, INC.
$25
Alexion Pharmaceuticals, Inc.
$24
Inari Medical, Inc.
$23
Puma Biotechnology, Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$22
Menarini Silicon Biosystems, Inc.
$21
Karyopharm Therapeutics Inc.
$21
Verity Pharmaceuticals Inc.
$21
Taiho Oncology, Inc.
$21
TOLMAR Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$20
Stemline Therapeutics Inc.
$19
Rigel Pharmaceuticals, Inc.
$17
Legend Biotech USA Inc.
$17
Amneal Pharmaceuticals LLC
$15
Boston Scientific Corporation
$13
Janssen Pharmaceuticals, Inc
$12
Clovis Oncology, Inc.
$11
Top 3 companies account for 58.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AUGTYRO · AVASTIN · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Cellsearch · DARZALEX · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · Fabhalta · Flexitouch Plus · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · MYRISK · Monoferric · NERLYNX · NINLARO · Neulasta · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rituxan · Rubraca · S · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · Stivarga · TABRECTA · TAGRISSO · TheraSphere Y90 Glass Microspheres 10 GBq · Trelstar · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · XYNTHA · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zoladex · Zydelig · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,550
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Malik is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Malik experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Malik performed 21,420 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Malik receive payments from pharmaceutical companies?
Yes. Dr. Malik received a total of $276,801 from 78 companies across 698 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malik's costs compare to other internal medicine physicians in Houston?
Dr. Malik's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Houston
Browse internal medicine physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology